CEBPD and triple-negative breast carcinoma: To assess an alternate triple-negative breast cancer cell line, we analyzed the combination of romidepsin and Stattic in MDA-MB-231 cells (Fig. 1C) and observed similar effects on C/EBPδ protein expression and H4 acetylation.